News & Updates
Filter by Specialty:

Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022
Dapagliflozin is a safe treatment to reduce the risk of worsening heart failure (HF) or cardiovascular death both in patients with and without history of recent HF hospitalization, a study has shown.
Dapagliflozin prevents worsening heart failure, CV death
06 Oct 2022
Smartphone app fails to boost MVPA in diabetics
06 Oct 2022
byTristan Manalac
Among patients with type 2 diabetes (T2D), use of the smartphone-based app InterWalk does not improve objective measures of moderate-to-vigorous physical activity (MVPA), according to a study.
Smartphone app fails to boost MVPA in diabetics
06 Oct 2022
Post-exposure doxycycline prevents STIs in MSM, TGW with HIV or on PrEP
05 Oct 2022
byRoshini Claire Anthony
Doxycycline, taken with 72 hours of unprotected sex, could prevent sexually transmitted infections (STIs) in men who have sex with men (MSM) or transgender women (TGW) who are either living with HIV (PLHIV) or are receiving pre-exposure prophylaxis (PrEP), according to a study presented at AIDS 2022.